Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 198 articles:
HTML format

Single Articles

    January 2022
  1. YU F, Zhou X, Jin X, Zhao S, et al
    Rational construction of controllable autoimmune diabetes model depicting clinical features.
    PLoS One. 2022;17:e0260100.
    PubMed     Abstract available

  2. OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
    Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
    PLoS One. 2022;17:e0261769.
    PubMed     Abstract available

  3. ARIF B, Arif Z, Ahmad J, Perveen K, et al
    Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
    PLoS One. 2022;17:e0262233.
    PubMed     Abstract available

  4. KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
    Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
    PLoS One. 2022;17:e0262677.
    PubMed     Abstract available

  5. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    PubMed     Abstract available

  6. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    PubMed     Abstract available

  7. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    PubMed     Abstract available

  8. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    PubMed     Abstract available

  9. PETROVA T, Bennett K, Nanda S, Strickson S, et al
    Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
    PLoS One. 2022;17:e0263151.
    PubMed     Abstract available

  10. LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022;17:e0263536.
    PubMed     Abstract available

  11. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    PubMed     Abstract available

  12. ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
    Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
    PLoS One. 2022;17:e0264118.
    PubMed     Abstract available

  13. BEDI S, Richardson TM, Jia B, Saab H, et al
    Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
    PLoS One. 2022;17:e0261103.
    PubMed     Abstract available

  14. TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
    Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0263774.
    PubMed     Abstract available

  15. QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
    Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    PLoS One. 2022;17:e0263511.
    PubMed     Abstract available

  16. LI JY, Sun XH, Shen DC, Yang XZ, et al
    Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
    PLoS One. 2022;17:e0266529.
    PubMed     Abstract available

  17. MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
    Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
    PLoS One. 2022;17:e0264626.
    PubMed     Abstract available

  18. KONG X, Diao S, Xu H, Sun J, et al
    Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
    PLoS One. 2022;17:e0266265.
    PubMed     Abstract available

  19. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    PubMed     Abstract available

  20. QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
    The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
    PLoS One. 2022;17:e0266809.
    PubMed     Abstract available

  21. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    PubMed     Abstract available

  22. CHEN X, Zhang Y, Luo Z, Wu Y, et al
    Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0264705.
    PubMed     Abstract available

  23. TANA MM, Klepper A, Lyden A, Pisco AO, et al
    Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    PLoS One. 2022;17:e0264307.
    PubMed     Abstract available

  24. NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
    Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    PLoS One. 2022;17:e0263778.
    PubMed     Abstract available

  25. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    PubMed     Abstract available

  26. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    PubMed     Abstract available

  27. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    PubMed     Abstract available

  28. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    PubMed     Abstract available

  29. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    PubMed     Abstract available

  30. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    PubMed     Abstract available

  31. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    PubMed     Abstract available

  32. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    PubMed     Abstract available

  33. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    PubMed     Abstract available

  34. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    PubMed     Abstract available

  35. RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
    The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
    PLoS One. 2022;17:e0267913.
    PubMed     Abstract available

  36. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    PubMed     Abstract available

  37. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    PubMed     Abstract available

  38. HIERL KV, Krause M, Kruber D, Sterker I, et al
    3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
    PLoS One. 2022;17:e0265324.
    PubMed     Abstract available

  39. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed     Abstract available

  40. IIDA M, Ohtomo S, Wada NA, Ueda O, et al
    TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
    PLoS One. 2022;17:e0265081.
    PubMed     Abstract available

  41. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    PubMed     Abstract available

  42. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    PubMed     Abstract available

  43. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    PubMed     Abstract available

  44. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    PubMed     Abstract available

  45. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    PubMed     Abstract available

  46. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    PubMed     Abstract available

  47. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    PubMed     Abstract available

  48. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    PubMed     Abstract available

  49. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    PubMed     Abstract available

  50. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available

  51. MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
    Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
    PLoS One. 2022;17:e0270142.
    PubMed     Abstract available

  52. HUANG Y, Wang WK, Zheng XM, Yang L, et al
    Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
    PLoS One. 2022;17:e0269621.
    PubMed     Abstract available

  53. PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
    IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
    PLoS One. 2022;17:e0270607.
    PubMed     Abstract available

  54. ALBURNO H, Mercken L, de Vries H, Al Mohannadi D, et al
    Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study.
    PLoS One. 2022;17:e0270984.
    PubMed     Abstract available

  55. RASKIN E, Achiron A, Zloto O, Neuman R, et al
    Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
    PLoS One. 2022;17:e0264918.
    PubMed     Abstract available

  56. HAYASHI K, Sada KE, Asano Y, Katayama Y, et al
    Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
    PLoS One. 2022;17:e0270569.
    PubMed     Abstract available

  57. KRAUSE A, Lee K, Konig D, Faist M, et al
    Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
    PLoS One. 2022;17:e0270698.
    PubMed     Abstract available

  58. AFYOUNI H, Haris B, Syed N, Ahmed I, et al
    Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar.
    PLoS One. 2022;17:e0271182.
    PubMed     Abstract available

  59. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study.
    PLoS One. 2022;17:e0271055.
    PubMed     Abstract available

  60. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    PubMed     Abstract available

  61. SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
    Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
    PLoS One. 2022;17:e0269466.
    PubMed     Abstract available

  62. BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
    A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
    PLoS One. 2022;17:e0269925.
    PubMed     Abstract available

  63. LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
    Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
    PLoS One. 2022;17:e0270890.
    PubMed     Abstract available

  64. VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
    Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0272156.
    PubMed     Abstract available

  65. UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
    Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
    PLoS One. 2022;17:e0272133.
    PubMed     Abstract available

  66. TU H, Li N, Liu W, Fan Z, et al
    Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0269371.
    PubMed     Abstract available

  67. PAPADIMITRIOU E, Boutzios G, Mathioudakis AG, Vlahos NF, et al
    Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0260759.
    PubMed     Abstract available

  68. QIU LNY, Cai SV, Chan D, Hess RS, et al
    Seasonality and geography of diabetes mellitus in United States of America dogs.
    PLoS One. 2022;17:e0272297.
    PubMed     Abstract available

  69. MAHMOUD RH, Fouad NA, Hefzy EM, Shaker OG, et al
    The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.
    PLoS One. 2022;17:e0268176.
    PubMed     Abstract available

  70. MORRISON AE, Chong K, Senior PA, Lam A, et al
    A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    PLoS One. 2022;17:e0271096.
    PubMed     Abstract available

  71. HOHN A, McGurnaghan SJ, Caparrotta TM, Jeyam A, et al
    Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018.
    PLoS One. 2022;17:e0271110.
    PubMed     Abstract available

  72. CRABTREE E, Uribe K, Smith SM, Roberts D, et al
    Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
    PLoS One. 2022;17:e0270972.
    PubMed     Abstract available

  73. LI Y, Yu X, Zhang W, Lv J, et al
    Epidemiological characteristics and pathological changes of primary glomerular diseases.
    PLoS One. 2022;17:e0272237.
    PubMed     Abstract available

  74. CHOI YJ, Kim C, Choi EW, Lee SH, et al
    MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    PLoS One. 2022;17:e0270416.
    PubMed     Abstract available

  75. SEKIGUCHI K, Ishizuchi K, Takizawa T, Motegi H, et al
    Anemia in female patients with myasthenia gravis.
    PLoS One. 2022;17:e0273720.
    PubMed     Abstract available

  76. STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
    The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
    PLoS One. 2022;17:e0268421.
    PubMed     Abstract available

  77. VIROONLUECHA P, Egea-Lopez E, Santa J
    Evaluation of blood glucose level control in type 1 diabetic patients using deep reinforcement learning.
    PLoS One. 2022;17:e0274608.
    PubMed     Abstract available

  78. TAKASHI Y, Maeda Y, Toyokawa K, Oda N, et al
    Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes.
    PLoS One. 2022;17:e0274182.
    PubMed     Abstract available

  79. JOH K, Nakazato T, Hashiguchi A, Shimizu A, et al
    Structural modeling for Oxford histological classifications of immunoglobulin A nephropathy.
    PLoS One. 2022;17:e0268731.
    PubMed     Abstract available

  80. LAROCQUE JC, Gardy S, Sammut M, McBey DP, et al
    Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0273701.
    PubMed     Abstract available

  81. YOSHIKAWA H, Adachi Y, Nakamura Y, Kuriyama N, et al
    Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018.
    PLoS One. 2022;17:e0274161.
    PubMed     Abstract available

  82. CARREIRA M, Ruiz de Adana MS, Pinzon JL, Anarte-Ortiz MT, et al
    Internet-based Cognitive-behavioral therapy (CBT) for depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study): A randomized controlled trial protocol.
    PLoS One. 2022;17:e0274551.
    PubMed     Abstract available

  83. KUENDIG S, Kool J, Polhemus A, Schallert W, et al
    Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability.
    PLoS One. 2022;17:e0274348.
    PubMed     Abstract available

  84. SMAOUI MR, Lafi A
    Leeno: Type 1 diabetes management training environment using smart algorithms.
    PLoS One. 2022;17:e0274534.
    PubMed     Abstract available

  85. NING L, Wang B
    Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0274565.
    PubMed     Abstract available

  86. ABUAF AF, Bunting SR, Klein S, Carroll T, et al
    Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
    PLoS One. 2022;17:e0274778.
    PubMed     Abstract available

  87. ALMAZROUEI R, Sharma C, Afandi B, Aldahmani KM, et al
    Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
    PLoS One. 2022;17:e0264545.
    PubMed     Abstract available

  88. DING MY, Li B, Yang M, Zhai WS, et al
    Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis.
    PLoS One. 2022;17:e0275122.
    PubMed     Abstract available

  89. YAMAGUCHI M, Ito M, Sugiyama H, Iwagaitsu S, et al
    Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.
    PLoS One. 2022;17:e0274483.
    PubMed     Abstract available

  90. GUIMARAES JAR, Furtado SDC, Lucas ACDS, Mori B, et al
    Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
    PLoS One. 2022;17:e0275016.
    PubMed     Abstract available

  91. JENSEN MH, Cichosz SL, Gustenhoff P, Nikontovic A, et al
    Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    PLoS One. 2022;17:e0274626.
    PubMed     Abstract available

  92. STORRAR J, Gill-Taylor T, Chinnadurai R, Chrysochou C, et al
    A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
    PLoS One. 2022;17:e0276053.
    PubMed     Abstract available

  93. MASIS L, Kanya L, Kiogora J, Kiapi L, et al
    Estimating treatment costs for uncomplicated diabetes at a hospital serving refugees in Kenya.
    PLoS One. 2022;17:e0276702.
    PubMed     Abstract available

  94. SELVARAJ MS, Paruchuri K, Haidermota S, Bernardo R, et al
    Genome-wide discovery for diabetes-dependent triglycerides-associated loci.
    PLoS One. 2022;17:e0275934.
    PubMed     Abstract available

  95. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    PubMed     Abstract available

  96. AMATYA M, Pant AD
    Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
    PLoS One. 2022;17:e0276172.
    PubMed     Abstract available

  97. DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
    Low serum uromodulin levels and their association with lupus flares.
    PLoS One. 2022;17:e0276481.
    PubMed     Abstract available

  98. CHEN W, Yu Y, Liu Y, Song C, et al
    Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats.
    PLoS One. 2022;17:e0277061.
    PubMed     Abstract available

  99. RICCI S, Perugia F, Piccini B, Lodi L, et al
    DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy.
    PLoS One. 2022;17:e0276896.
    PubMed     Abstract available

  100. BAYARMUNKH O, Ganbold C, Das S, Davaatseren U, et al
    Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    PLoS One. 2022;17:e0277055.
    PubMed     Abstract available

  101. BOYARCHUK O, Dobrovolska L, Svystunovych H
    Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine.
    PLoS One. 2022;17:e0277273.
    PubMed     Abstract available

    January 2021
  102. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    PubMed     Abstract available

  103. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    PubMed     Abstract available

  104. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    PubMed     Abstract available

  105. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available

  106. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    PubMed     Abstract available

  107. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    PubMed     Abstract available

  108. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    PubMed     Abstract available

  109. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available

  110. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    PubMed     Abstract available

  111. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    PubMed     Abstract available

  112. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    PubMed     Abstract available

  113. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    PubMed     Abstract available

  114. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    PubMed     Abstract available

  115. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    PubMed     Abstract available

  116. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    PubMed     Abstract available

  117. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    PubMed     Abstract available

  118. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available

  119. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    PubMed     Abstract available

  120. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    PubMed     Abstract available

  121. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    PubMed     Abstract available

  122. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    PubMed     Abstract available

  123. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    PubMed     Abstract available

  124. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    PubMed     Abstract available

  125. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    PubMed     Abstract available

  126. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    PubMed     Abstract available

  127. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    PubMed     Abstract available

  128. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    PubMed     Abstract available

  129. LUU T, Cheung JF, Baccon J, Waldner H, et al
    Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2021;16:e0250340.
    PubMed     Abstract available

  130. SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
    Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
    PLoS One. 2021;16:e0250215.
    PubMed     Abstract available

  131. LIU GY, Wu Y, Kong FY, Ma S, et al
    BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
    PLoS One. 2021;16:e0243014.
    PubMed     Abstract available

  132. SATITPITAKUL V, Rattanaphong T, Pruksakorn V
    Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
    PLoS One. 2021;16:e0250617.
    PubMed     Abstract available

  133. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    PubMed     Abstract available

  134. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    PubMed     Abstract available

  135. ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
    Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    PLoS One. 2021;16:e0248280.
    PubMed     Abstract available

  136. SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
    B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
    PLoS One. 2021;16:e0248056.
    PubMed     Abstract available

  137. SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
    Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    PLoS One. 2021;16:e0248845.
    PubMed     Abstract available

  138. CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
    Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
    PLoS One. 2021;16:e0247901.
    PubMed     Abstract available

  139. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    PubMed     Abstract available

  140. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    PubMed     Abstract available

  141. SATO H, Ichikawa D, Okada E, Suzuki T, et al
    Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    PLoS One. 2021;16:e0251294.
    PubMed     Abstract available

  142. LU Z, Liu W, Gao H, Chen W, et al
    Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251131.
    PubMed     Abstract available

  143. FATOYE F, Gebrye T, Svenson LW
    Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    PLoS One. 2021;16:e0251409.
    PubMed     Abstract available

  144. LIAO K, Chen K, Brett S, Gehman A, et al
    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
    PLoS One. 2021;16:e0249049.
    PubMed     Abstract available

  145. CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
    Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
    PLoS One. 2021;16:e0252236.
    PubMed     Abstract available

  146. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    PubMed     Abstract available

  147. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available

  148. STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
    PLoS One. 2021;16:e0254859.
    PubMed     Abstract available

  149. MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
    Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    PLoS One. 2021;16:e0255317.
    PubMed     Abstract available

  150. NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
    Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0251709.
    PubMed     Abstract available

  151. HOFFMAN WH, Whelan SA, Lee N
    Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
    PLoS One. 2021;16:e0254116.
    PubMed     Abstract available

  152. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    PubMed     Abstract available

  153. SWANN JW, Tayler S, Hall H, Sparrow R, et al
    Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    PLoS One. 2021;16:e0257700.
    PubMed     Abstract available

  154. MCCALL JL, Blair HC, Blethen KE, Hall C, et al
    Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
    PLoS One. 2021;16:e0249442.
    PubMed     Abstract available

  155. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    PubMed     Abstract available

  156. KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
    Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    PLoS One. 2021;16:e0254718.
    PubMed     Abstract available

  157. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
    PLoS One. 2021;16:e0254226.
    PubMed     Abstract available

  158. JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
    Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
    PLoS One. 2021;16:e0253844.
    PubMed     Abstract available

  159. BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
    Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    PLoS One. 2021;16:e0254079.
    PubMed     Abstract available

  160. NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    PLoS One. 2021;16:e0253793.
    PubMed     Abstract available

  161. FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
    Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
    PLoS One. 2021;16:e0253389.
    PubMed     Abstract available

  162. VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
    Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
    PLoS One. 2021;16:e0253125.
    PubMed     Abstract available

  163. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    PubMed     Abstract available

  164. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    PubMed     Abstract available

  165. WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
    Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
    PLoS One. 2021;16:e0252588.
    PubMed     Abstract available

  166. WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
    Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
    PLoS One. 2021;16:e0252638.
    PubMed     Abstract available

  167. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    PubMed     Abstract available

  168. ROZYCKA J
    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    PubMed     Abstract available

  169. PARIKH RV, Tan TC, Fan D, Law D, et al
    Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    PLoS One. 2021;16:e0257674.
    PubMed     Abstract available

  170. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    PubMed     Abstract available

  171. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    PubMed     Abstract available

  172. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    PubMed     Abstract available

  173. JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
    Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    PLoS One. 2021;16:e0255344.
    PubMed     Abstract available

  174. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    PubMed     Abstract available

  175. SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
    PLoS One. 2021;16:e0254634.
    PubMed     Abstract available

  176. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    PubMed     Abstract available

  177. TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
    Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    PLoS One. 2021;16:e0258090.
    PubMed     Abstract available

  178. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    PubMed     Abstract available

  179. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available

  180. KIM SS, Hudgins AD, Yang J, Zhu Y, et al
    A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    PLoS One. 2021;16:e0257265.
    PubMed     Abstract available

  181. OSAKI T, Souri M, Ichinose A
    Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
    PLoS One. 2021;16:e0257322.
    PubMed     Abstract available

  182. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    PubMed     Abstract available

  183. NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
    PLoS One. 2021;16:e0257154.
    PubMed     Abstract available

  184. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    PubMed     Abstract available

  185. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    PubMed     Abstract available

  186. PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
    Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2021;16:e0256140.
    PubMed     Abstract available

  187. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    PubMed     Abstract available

  188. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    PubMed     Abstract available

  189. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    PubMed     Abstract available

  190. RENAUD A, Caristan A, Seguin A, Agard C, et al
    Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
    PLoS One. 2021;16:e0260196.
    PubMed     Abstract available

  191. BOCH K, Drager S, Zillikens D, Hudemann C, et al
    Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
    PLoS One. 2021;16:e0259586.
    PubMed     Abstract available

  192. HSU CY, Chueh YS, Kuo ML, Lee PT, et al
    Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    PLoS One. 2021;16:e0261727.
    PubMed     Abstract available

  193. BLUTHGEN C, Patella M, Euler A, Baessler B, et al
    Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
    PLoS One. 2021;16:e0261401.
    PubMed     Abstract available

  194. COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
    The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
    PLoS One. 2021;16:e0260896.
    PubMed     Abstract available

  195. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    PubMed     Abstract available

  196. MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
    Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
    PLoS One. 2021;16:e0262171.
    PubMed     Abstract available

  197. CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
    Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    PLoS One. 2021;16:e0261983.
    PubMed     Abstract available

  198. MIDTHASSEL TC, Hansen AH
    Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
    PLoS One. 2021;16:e0261471.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.